- Home
- TC vs VALN Comparison
TC vs VALN Comparison
Compare TC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- VALN
- Stock Information
- Founded
- TC 2010
- VALN 2012
- Country
- TC China
- VALN France
- Employees
- TC N/A
- VALN N/A
- Industry
- TC Business Services
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TC Consumer Discretionary
- VALN Health Care
- Exchange
- TC Nasdaq
- VALN Nasdaq
- Market Cap
- TC N/A
- VALN 510.7M
- IPO Year
- TC 2018
- VALN 2021
- Fundamental
- Price
- TC $0.63
- VALN $6.38
- Analyst Decision
- TC
- VALN Strong Buy
- Analyst Count
- TC 0
- VALN 3
- Target Price
- TC N/A
- VALN $15.33
- AVG Volume (30 Days)
- TC 15.8K
- VALN 15.0K
- Earning Date
- TC 05-16-2025
- VALN 05-07-2025
- Dividend Yield
- TC N/A
- VALN N/A
- EPS Growth
- TC N/A
- VALN N/A
- EPS
- TC N/A
- VALN N/A
- Revenue
- TC $6,737,269.00
- VALN $201,099,222.00
- Revenue This Year
- TC N/A
- VALN $17.98
- Revenue Next Year
- TC N/A
- VALN $26.61
- P/E Ratio
- TC N/A
- VALN N/A
- Revenue Growth
- TC N/A
- VALN 21.64
- 52 Week Low
- TC $0.46
- VALN $3.62
- 52 Week High
- TC $4.30
- VALN $9.50
- Technical
- Relative Strength Index (RSI)
- TC 51.74
- VALN 44.94
- Support Level
- TC $0.52
- VALN $6.25
- Resistance Level
- TC $0.65
- VALN $6.65
- Average True Range (ATR)
- TC 0.04
- VALN 0.32
- MACD
- TC 0.01
- VALN -0.02
- Stochastic Oscillator
- TC 86.62
- VALN 20.35
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.